Company
Who We Are
News
Product
Extracellular vesicles
EV isolation
EV characterization
Technology
Overview
Therapy
Diagnosis
Publish
Services
EV & exosome isolation
and QC
Support
FAQ
Contact Us
Notice
Search
MSC derived EV
Plant Derived EV
Exo2D
TM
- for RNA & Protein
ExoCope
Therapy
Diagnosis
Solutions Tailored for Your Needs
We have breakthrough solutions and know-how
for your exosome research and utilization
Who We Are
News
HOME
·
COMPANY
·
News
엑소좀플러스, 27억 pre-시리즈A 투자 유치
관리자 │ 2019-04-22
HIT
405053
http://m.biospectator.com/view/news_view.php?varAtcId=7427&ref=https%3A%2F%2Fm.facebook.com%2F
List
Prev
마크로젠-엑소좀플러스, 바이오제약시장 공동 진출 추진 엑...
Next
(주)엑소좀플러스 제2기 정기 주주총회 개최에 따른 안내